|
Report Date : |
30.10.2014 |
IDENTIFICATION DETAILS
|
Name : |
FARMAK, A.S. |
|
|
|
|
Registered Office : |
Na Vlčinci 16/3, 779 00 Olomouc |
|
|
|
|
Country : |
Czech Republic |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
09.09.1992 |
|
|
|
|
Com. Reg. No.: |
B 457 |
|
|
|
|
Legal Form : |
Public Limited Company
|
|
|
|
|
Line of Business : |
|
|
|
|
|
No of Employees : |
239 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Czech Republic |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CZECH REPUBLIC - ECONOMIC OVERVIEW
The Czech Republic is a
stable and prosperous market economy closely integrated with the EU, especially
since the country's EU accession in 2004. The auto industry is the largest single
industry, and, together with its upstream suppliers, accounts for nearly 24% of
Czech manufacturing. The Czech Republic produced more than a million cars for
the first time in 2010, over 80% of which were exported. While the
conservative, inward-looking Czech financial system has remained relatively
healthy, the small, open, export-driven Czech economy remains sensitive to
changes in the economic performance of its main export markets, especially
Germany. When Western Europe and Germany fell into recession in late 2008,
demand for Czech goods plunged, leading to double digit drops in industrial
production and exports. As a result, real GDP fell sharply in 2009. The economy
slowly recovered in the second half of 2009 and registered weak growth in the next
two years. In 2012, however, the economy fell into a recession again, due both
to a slump in external demand and to the government’s austerity measures. The
country pulled out of recession in the second half of 2013, and most analysts
expect modest, but steady, growth through 2014. Foreign and domestic businesses
alike voice concerns about corruption, especially in public procurement. Other
long term challenges include dealing with a rapidly aging population, funding
an unsustainable pension and health care system, and diversifying away from
manufacturing and toward a more high-tech, services-based, knowledge economy.
|
Source
: CIA |
FARMAK, A.S.
Na vlčinci 16/3
779 00 Olomouc
Telephone: 00420/ 585 547 111
Telefax: 00420/ 585 231 735
E-mail: ceo@farmak.cz
Web: www.farmak.cz
Legal form Public
limited company
Foundation 09/09/1992
- Public limited company
Comp. Register 09/09/1992,
Krajský soud v Ostravě, RegNr.: B 457
Statistical number: 45192961
Tax number: CZ45192961
Share Capital 09/09/1992 CZK 5.905.000,-
06/05/1998 CZK 29.525.000,-
24/10/2000 CZK 29.525.000,-
19/07/2003 CZK 59.050.000,-
01/09/2009 CZK 59.350.000,-
1000 pc of priority registered shares in
documentary form at
nominal value of CZK 10.000,- 60 pc of priority
registered
shares in
documentary form at nominal value of CZK 15.000,-
4.845 pc of priority registered shares in
documentary form at
nominal value
of CZK 10.000,-
Main
Ing. Jiří Žák
(08.03.1937) % 82,05
Shareholder
Zlechov 72, 687 10
Zlechov
Board of
Ing. Jiří Žák (08.03.1937)
Directors
Zlechov 72, 687 10
Zlechov
chairman of
board
Tel:00420/ 585
547 402
Mgr. Bronislava
Paučková (03.03.1963)
Keltská 816/29,
779 00 Olomouc, Neředín
vice-chairman
of board
Tel:00420/ 585
547 425
ing. Bořivoj
Frýbert (25.06.1945)
Ukrajinská
10/1488, 101 00 Praha 10, Vršovice
Ing. Jiří
Křepelka, CSc. (13.01.1944)
Mikovická
875, 728 01 Kralupy nad Vltavou
Marta Paučková
(14.05.1991)
Keltská 816/
29, 779 00 Olomouc, Neředín
Supervisory
JUDr.Ing. Josef Škoda
(18.10.1942)
Board
U Okrouhlíku
1820/3, 150 00 Praha 5, Smíchov
chairman of
supervisory board
Ing. Ondřej
Pauček (21.10.1983)
Dělnická
435/22, 779 00 Olomouc, Neředín
Ing. Veronika
Paučková (26.03.1985)
Dělnická
435/22, 779 00 Olomouc
General Data Manufacture
and sale of active pharmaceutical ingredients,
manufacture and
sale of intermediate products and chemical
specialties.
Main activity:
Manufacture of
basic pharmaceutical products
(21.10)
Trade
name(s)
FARMAK, a.s.
Beginning of
validity: 09.09.1992
Export: 82%
Japan
USA
India
European
Union
Switzerland
Import:
France
USA
Germany
General
contacts:
telephone:
00420/ 585 547
111
telefax:
00420/ 585 231
735
e-mail:
ceo@farmak.cz
Web:
www.farmak.cz
Address:
Na vlčinci
16/3, 779 00 Olomouc
Beginning of
validity: 19.11.2012
Na Vlčinci
16/3, 771 17 Olomouc, Klášterní Hradisko
Beginning
of validity: 24.09.2001
End of
validity: 19.11.2012
Na Vlčinci 3,
Olomouc
Beginning
of validity: 09.09.1992
End of
validity: 24.09.2001
Staff
2008 274 employees
2009 259
employees
2010 246 employees
2011 243 employees
2012 236 employees
2013 232 employees
2014 239 employees
Annual Sales 2005 actual sales
CZK 389.381.000,-
2006 actual sales
CZK 408.694.000,-
2007 actual sales CZK 471.042.000,-
2008 actual sales
CZK 426.406.000,-
2009 actual sales CZK
387.358.000,-
2010 actual sales
CZK 396.654.000,-
2011 actual sales
CZK 389.865.000,-
2012 actual sales
CZK 398.768.000,-
2013 actual sales
CZK 348.328.000,-
The company is not registered in the
Central register of
executions.
Balance sheets
The enclosed profit/loss account of 2013 is originated from
other source, it is authenticated by the auditor. (31.12.2013 -
1 CZK)
The enclosed profit/loss account of 2012 company's own data, it is
authenticated by the auditor. (31.12.2012 - 1 CZK)
The enclosed profit/loss account of 2011 from business register, it is
authenticated by the auditor. (31.12.2011 - 1 CZK)
The enclosed balance of 2013 is originated from other source,
it is authenticated by the
auditor. (31.12.2013 - 1 CZK)
The enclosed balance of 2012 company's own data, it is authenticated by
the auditor. (31.12.2012 - 1 CZK)
The enclosed balance of 2011 from business register, it is authenticated
by the auditor. (31.12.2011 - 1 CZK)
Remarks The company is a holder of ISO 9001
and ISO 14001 certificates.
All the sources of negative data accessible to public
(insolvency registers, databases of debtors of health
insurance institutions, commercial bulletin, collection
database of Creditreform and others) are currently monitored.
Business management:
Ing. Roman Grunt – general director
Ing. Jiří Raška, Ph.D. – business director, phone 00420/ 585
547 219
Ing. Jiří Kaufman – financial director, phone 00420/ 587 430
215
Prof. Ing. Pavel Hradil, CSc. – director for research and
development
Ing. Leopold Doubek –
production director, phone. 00420/ 587
430 214
Ing. Luděk Minář – service section director
Soňa Svozilová – chief accountant
Other entrepreneurial interests:
Ing. Jiří Žák
- FARMAK - GASTRO s.r.o., IČ 26839296, executive, associate
40%
- FARMAK MORAVIA, a.s., IČ 7677457, chairman of the Board of
Directors
- CZECH-GEN a.s., IČ 29446724 - chairman of the Board of
Directors
As of 1.1.1996, the company
FARMAK, a.s. has assumed all
volume of production and business
activity of the state
FARMAKON, s.p. The original firm was founded in 1934.
The company FARMAK, a.s., IČ 45192961, was divided in form of
division by split-off and marger, namely by merger of the
split-off part of property with
the successor company FARMAK
MORAVIA, a.s., IČ: 47677457, to
which the part of property of
the divided company FARMAK, a.s.
defined in the Project of
division by split-off with
merger has been transferred.
Record date of division was 1.1.2009.
Bankers Komerční banka, a.s. (0100)
Account number: 19-1094570227/ (0600)
0100
Account number: 19-1094590287/
0100
Account number: 3604811/0100
GE Money Bank, a.s.
Account number: 197655130/0600
Copyright:
This information is addressed exclusively to the addressee.
Creditreform
Contractor obligates to provide updated information. Although
s.r.o. Praha
it is always put maximum effort to collect actual and exact
information, it is not confirmed as delinquency if there are
particular inaccurateness contained
within the information,
which are not considered as essential in terms of the
objective for which the information is provided to the
addressee. Contractor and recipient conform to the rules of
the Name and Description Security Act, Nub.101/2000. According
to the Name and Description Security Act, recipient has the
right to process or to use forwarding data only for the
purpose for which information has been sent to the recipient.
Usage for other purpose is acceptable only in case referring
to valid regulations of the above mentioned act.
balance 31.12.2010 31.12.2011
31.12.2012 31.12.2013
(CZK) (CZK) (CZK) (CZK)
>r1 >TOTAL ASSETS >740.715.000 >788.510.000 >801.636.000 >830.059.000
r2 Receivables for 0 0 0 0
subscriptions
>r3 >Fixed assets >316.662.000 >302.685.000 >297.010.000 >310.471.000
>r4 >Intangible fixed >2.223.000 >2.694.000 >2.258.000 >2.180.000
assets
r5 Incorporation expenses 0
r6 Research and 0
development
r7 Software 1.165.000 1.083.000 493.000 138.000
r8 Valuable rights 83.000 543.000 447.000 426.000
r9 Goodwill 0
r10 Other intangible 0
fixed
assets
r11 Intangible fixed 975.000 1.068.000 1.318.000 1.616.000
assets
under
construction
r12 Advance payments for 0
intangible
fixed
assets
>r13 >Tangible fixed assets >314.439.000 >298.632.000 >292.973.000 >306.512.000
r14 Lands 18.560.000 18.560.000
18.560.000 18.560.000
r15 Constructions 193.338.000 205.144.000
194.691.000 179.602.000
r16 Equipment 70.169.000 69.052.000
74.058.000 69.941.000
r17 Perennial corps 0
r18 Breeding and draught 0
animals
r19 Other tangible fixed 266.000 266.000 266.000 266.000
assets
r20 Tangible fixed assets 32.106.000 2.304.000 4.096.000
37.772.000
under
construction
r21 Advance payments for 0 3.306.000 1.302.000 371.000
tangible
fixed assets
r22 Adjustment to 0
acquired
assets
>r23 >Long-term financial >0 >1.359.000 >1.779.000 >1.779.000
assets
r24 Shares in controlled 0
and managed
organizations
r25 Shares in accounting 0 1.359.000 1.779.000 1.779.000
units
with
substantial
influence
r26 Other securities and 0
shares
r27 Loans to controlled 0
and
managed
organizations and to
accounting
unit with
substantial
influence
r28 Other financial 0
investments
r29 Financial investments 0
acquired
r30 Advance payments for 0
long-term
financial
assets
>r31 >Current assets >422.294.000 >484.106.000 >502.710.000 >516.654.000
>r32 >Inventory >154.588.000 >182.483.000 >178.337.000 >178.651.000
r33 Materials 32.691.000 40.294.000
40.484.000 33.197.000
r34 Work in progress and 44.538.000 42.801.000
66.157.000 64.971.000
semi-products
r35 Finished products 71.561.000 90.969.000
68.441.000 78.512.000
r36 Animals 0
r37 Merchandise 5.736.000 1.812.000 3.102.000 1.779.000
r38 Advance payments for 62.000 6.607.000 153.000 192.000
inventory
>r39 >Long-term receivables >0 >0 >0 >0
r40 Trade receivables 0
r41 Receivables from 0
controlled
and
managed
organizations
r42 Receivables from 0
accounting
units with
substantial
influence
r43 Receivables from 0
partners,
cooperative
members
and
association
members
r44 Long-term deposits 0
given
r45 Estimated receivable 0
r46 Other receivables 0
r47 Deferred tax 0
receivable
>r48 >Short-term >56.417.000 >87.594.000 >86.744.000 >53.627.000
receivables
r49 Trade receivables 43.415.000 74.316.000
81.222.000 48.992.000
r50 Receivables from 0
controlled
and
managed
organizations
r51 Receivables from 0
accounting
units with
substantial
influence
r52 Receivables from 0
partners,
cooperative
members
and
association
members
r53 Receivables from 0
social
security and
health
insurance
r54 Due from state - tax 12.646.000 12.453.000 5.164.000 4.121.000
receivable
r55 Short-term deposits 330.000 693.000 222.000 241.000
given
r56 Estimated receivable 2.000 120.000 122.000 9.000
r57 Other receivables 24.000 12.000 14.000 264.000
>r58 >Short-term financial >211.289.000 >214.029.000 >237.629.000 >284.376.000
assets
r59 Cash 66.000 129.000 185.000 121.000
r60 Bank accounts
191.995.000 196.020.000
218.654.000 261.550.000
r61 Short-term securities 19.228.000 17.880.000
18.790.000 22.705.000
and
ownership
interests
r62 Short-term financial 0
assets
acquired
>r63 >Accruals >1.759.000 >1.719.000
>1.916.000 >2.934.000
r64 Deferred expenses 1.709.000 1.688.000 1.888.000 2.740.000
r65 Complex deferred costs 0
r66 Deferred income 50.000 31.000 28.000 194.000
>r67 >TOTAL LIABILITIES >740.715.000 >788.510.000 >801.636.000 >830.059.000
>r68 >Equity >527.333.000 >563.951.000 >593.309.000 >613.163.000
>r69 >Registered capital >59.350.000 >59.350.000 >59.350.000 >59.350.000
r70 Registered capital 59.350.000 59.350.000
59.350.000 59.350.000
r71 Company’s own shares 0
and
ownership
interests
(-)
r72 Changes of registered 0
capital (
+/- )
>r73 >Capital funds >19.000 >19.000 >19.000 >19.000
r74 Share premium 0
r75 Other capital funds 0
r76 Differences from -10.000 -10.000 -10.000 -10.000
revaluation
of assets
and
liabilities ( +/-
)
r77 Differences from 29.000 29.000
revaluation
in
transformation ( +/- )
Diferences
from
29.000 29.000
tranformation of
companies (
+/- )
>r78 >Reserve funds, >12.665.000 >13.056.000 >12.838.000 >13.126.000
statutory
reserve
account
for
cooperatives, and
other
retained
earnings
r79 Legal reserve fund / 11.870.000 11.870.000
11.870.000 11.870.000
indivisible
fund
r80 Statutory and other 795.000 1.186.000 968.000 1.256.000
funds
>r81 >Profit / loss - >434.243.000 >453.808.000 >490.826.000 >515.302.000
previous
years
r82 Retained earnings 434.243.000 453.808.000
490.826.000 515.302.000
from
previous years
r83 Accumulated losses 0
from
previous years
>r84 >Profit / loss - >21.056.000 >37.718.000 >30.276.000 >25.366.000
current
year (+/-)
>r85 >Liabilities >212.773.000 >215.435.000 >204.868.000 >216.187.000
>r86 >Reserves >0 >150.000 >0 >0
r87 Reserves under 0
special
statutory
regulations
r88 Reserves for pension 0
and similar
payables
r89 Income tax reserves 0
r90 Other reserves 0 150.000
>r91 >Long-term payables >12.527.000 >12.148.000 >12.743.000 >11.238.000
r92 Trade payables 0
r93 Payables to 0
controlled
and
managed
organizations
r94 Payables to 0
accounting
units with
substantial
influence
r95 Payables from 0
partners,
cooperative
members
and
association
members
r96 Long-term advances 0
received
r97 Issues bonds 0
r98 Long-term notes 0
payables
r99 Estimated payables 0
r100 Other payables 0
r101 Deferred tax liability 12.527.000 12.148.000
12.743.000 11.238.000
>r102 >Short-term payables >34.269.000 >46.033.000 >33.944.000 >48.166.000
r103 Trade payables 12.757.000 11.859.000 8.951.000
32.798.000
r104 Payables to 0
controlled
and
managed
organizations
r105 Payables to 0
accounting
units with
substantial
influence
r106 Payables from 2.000 4.000 4.000
2.000
partners,
cooperative
members
and
association
members
r107 Payroll 5.089.000 5.093.000
10.097.000 5.397.000
r108 Payables to social 2.697.000 2.762.000 3.688.000 2.995.000
securities
and health
insurance
r109 Due from state - tax 636.000 4.024.000 1.709.000 796.000
liabilities
and
subsidies
r110 Short-term deposits 10.159.000 9.288.000 8.951.000 5.692.000
received
r111 Issues bonds 0
r112 Estimated payables 2.928.000 368.000 544.000 480.000
r113 Other payables 1.000 12.635.000 6.000
>r114 >Bank loans and >165.977.000 >157.104.000 >158.181.000 >156.783.000
financial
accommodations
r115 Long-term bank loans 0 0 0 0
r116 Short-term bank loans 165.977.000
157.104.000 158.181.000 156.783.000
r117 Short-term 0 0 0 0
accommodations
>r118 >Accruals >609.000 >9.124.000 >3.459.000 >709.000
r119 Accrued expenses 609.000 9.124.000 3.459.000 709.000
r120 Deferred revenues 0
profit/loss
account 31.12.2010 31.12.2011
31.12.2012 31.12.2013
(CZK) (CZK) (CZK) (CZK)
>a1 >Turnover >396.654.000 >389.865.000 >398.768.000 >348.328.000
a2 Revenues from sold 4.682.000 4.061.000 45.000 4.573.000
goods
a3 Expenses on sold goods 4.035.000 4.455.000 25.000 3.039.000
>a4 >Sale margin >647.000 >-394.000 >20.000 >1.534.000
>a5 >Production >387.007.000 >404.278.000 >404.276.000 >357.330.000
a6 Revenues from own 391.972.000 385.804.000
398.723.000 343.755.000
products
and services
a7 Change in inventory -5.268.000 17.664.000 827.000 8.885.000
of own
products
a8 Capitalization 303.000
810.000 4.726.000 4.690.000
>a9 >Production >210.999.000 >203.663.000 >202.410.000 >201.892.000
consumption
a10 Consumption of 150.177.000 151.873.000
147.257.000 148.132.000
material
and energy
a11 Services 60.822.000 51.790.000
55.153.000 53.760.000
>a12 >Added value >176.655.000 >200.221.000 >201.886.000 >156.972.000
>a13 >Personnel expenses >112.820.000 >117.608.000 >116.767.000 >105.711.000
a14 Wages and salaries 80.717.000 83.858.000
84.560.000 74.761.000
a15 Renumeration of board 1.740.000 2.010.000 2.380.000 2.400.000
members
a16 Social security 27.962.000 29.443.000
27.448.000 26.202.000
expenses
and health
insurance
a17 Other social expenses 2.401.000 2.297.000 2.379.000 2.348.000
a18 Taxes and fees 1.047.000 775.000 811.000 1.786.000
a19 Depreciations of 36.933.000 37.606.000
39.497.000 37.213.000
intangible
and
tangible
assets
>a20 >Revenues from >1.042.000 >2.511.000 >1.397.000 >1.543.000
disposals
of fixed
assets and
materials
a21 Revenues from 0 34.000 200.000 501.000
disposals
of fixed
assets
a22 Revenues from 1.042.000 2.477.000 1.197.000 1.042.000
disposals
of materials
>a23 >Net book value of >643.000 >359.000 >337.000 >520.000
disposed
fixed assets
and
materials
a24 Net book value of 0 290.000
sold fixed
assets
a25 Net book value of 643.000 359.000 337.000 230.000
sold
material
a26 Change in operating 120.000 433.000 119.000
7.907.000
reserves
and
adjustments
and
complex
deferred
costs ( + /
- )
a27 Other operating 13.401.000 616.000 189.000 803.000
revenues
a28 Other operating 3.387.000 2.904.000 2.504.000 2.698.000
expenses
a29 Transfer of operating 0
revenues
a30 Transfer of operating 0
expenses
>a31 >Operating profit / >36.148.000 >43.663.000 >43.437.000 >3.483.000
loss
a32 Revenues from sales 0
of
securities and
ownership
interests
a33 Sold securities and 0
ownership
interests
>a34 >Revenues from long- >0 >0
term
financial assets
a35 Revenues from shares 0
in
controlled and
managed
organizations
and in
accounting
units
with
substantial
influence
a36 Revenues from others 0
securities
and
ownership
interests
a37 Revenues from other 0
long-term
financial
assets
a38 Revenues from short- 0
term
financial assets
a39 Expenses associated 0
with
financial assets
a40 Revenues from 2.114.000 304.000 910.000 3.916.000
revaluation
of
securities
and
derivatives
a41 Cost of revaluation 0 1.652.000
of
securities and
derivatives
a42 Change in financial 0
reserves
and
adjustments
( + / - )
a43 Interest revenues 124.000 48.000 39.000 114.000
a44 Interest expenses 3.481.000 3.026.000 2.516.000 1.805.000
a45 Other financial 11.346.000 27.399.000
19.306.000 27.039.000
revenues
a46 Other financial 22.649.000 22.392.000
26.955.000 4.428.000
expenses
a47 Transfer of
0
financial
revenues
a48 Transfer of 0
financial
expenses
>a49 >Profit / loss from >-12.546.000 >681.000 >-9.216.000 >24.836.000
financial
operations
(
transactions )
>a50 >Income tax on >2.546.000 >6.626.000 >3.945.000 >2.953.000
ordinary
income
a51 Due tax 2.435.000 7.006.000
3.350.000 4.458.000
a52 Tax deferred 111.000 -380.000 595.000
-1.505.000
>a53 >Operating profit / >21.056.000 >37.718.000 >30.276.000 >25.366.000
loss
ordinary activity
a54 Extraordinary revenues 0
a55 Extraordinary expenses 0
>a56 >Income tax on >0 >0
extraordinary income
a57 Due tax 0
a58 Tax deferred 0
>a59 >Operating profit / >0 >0 >0 >0
loss
extraordinary
activity
a60 Transfer profit ( 0
loss ) to
partners (+/
-)
>a61 >Profit / loss of >21.056.000 >37.718.000 >30.276.000 >25.366.000
current
accounting
period (+/-)
>a62 >Profit / loss before >23.602.000 >44.344.000 >34.221.000 >28.319.000
tax
(+/-)
>
>Operating cash flow
>19.522.000
>36.307.000 >57.063.000 >100.205.000
>
>Investment cash flow
>-45.127.000 >-23.346.000
>-35.668.000 >-50.463.000
>
>Financial cash flow
>1.701.000
>-8.873.000 >1.295.000 >-6.910.000
>
>Receivables after
>6.678.000
>12.054.000 >5.747.000 >5.273.000
due date
total
Receivables
more than 851.000 141.000 305.000 291.000
180 days
after due
date
>
>Liabilities after
>208.000 >1.105.000 >757.000 >642.000
due date
total
Liabilities
more than 0 0 0 0
180 days
after due
date
Balance indices 31.12.2010 31.12.2011
31.12.2012 31.12.2013
Return on
a62/r1 * 3,19 5,62 4,27 3,41
total assets
100
ROA (in %)
Return on
a62/r68 4,48 7,86 5,77 4,62
equity ROE (in
* 100
%)
Return on
a62/a1 * 5,95
11,37 8,58 8,13
sales ROS (in
100
%)
Turnover of
r49/a1 * 39,95 69,58
74,34 51,34
receivables
365
(in days)
Turnover of
r103/a1 11,74 11,10 8,19
34,37
liabilities
* 365
(in days)
Turnover of
r32/a1 * 142,25 170,84 163,24 187,20
inventories
365
(days)
Net working
r31 - 222.048,00 280.969,00
310.585,00 311.705,00
capital (in
r102 -
ths. CZK)
r116 -
r117
Ratio of
(r39+ 120,56 150,55 185,80 90,28
accounts
r48) /
payable to
(r91+
accounts
r102) *
receivable (in
100
%)
Ratio of
r3 / a1 79,83 77,64 74,48 89,13
profit/loss to
* 100
tangible
assets (in%)
Current ratio
r31 / 2,11 2,38 2,62 2,52
(r102+
r116+
r117)
Quick ratio
(r58+ 1,34 1,48 1,69 1,65
r48) /
(r102+
r116+
r117)
Cash ratio r58 / 1,06 1,05 1,24 1,39
(r102+
r116+
r117)
Debt ratio I
(1-r68/ 28,81 28,48 25,99 26,13
(in %)
r67) *
100
Debt ratio II
r85/r67 28,73 27,32 25,56 26,04
(in %)
* 100
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.32 |
|
|
1 |
Rs.99.00 |
|
Euro |
1 |
Rs.78.14 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
SMN |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.